Macpee Tablet contains Bethanechol 25mg, a cholinergic agonist primarily used to stimulate bladder muscle contraction in patients with urinary retention or neurogenic bladder dysfunction. Bethanechol acts selectively on muscarinic receptors in the detrusor muscle of the bladder, promoting increased bladder tone and facilitating micturition. This medication is indicated for the treatment of postoperative urinary retention, atony of the bladder, and certain cases of gastrointestinal atony. Macpee Tablet is administered orally, with dosage tailored according to patient response and clinical condition. It is essential to monitor patients for potential adverse effects such as abdominal cramps, diarrhea, increased salivation, sweating, flushing, and hypotension, which are related to its parasympathomimetic activity. Contraindications include mechanical obstruction of the gastrointestinal or urinary tract, asthma, bradycardia, hypotension, and peptic ulcer disease. Caution is advised in patients with cardiovascular disorders or epilepsy. Macpee Tablet should be used under medical supervision, with careful assessment of renal and hepatic function prior to initiation. Proper adherence to prescribed dosage and monitoring for therapeutic efficacy and side effects are critical to ensure safe and effective use of Bethanechol in managing urinary retention and related conditions.